Tactile Systems Technology (Tactile Systems Technology) Interest Expense : $0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Tactile Systems Technology's interest expense for the three months ended in Mar. 2024 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Tactile Systems Technology's Operating Income for the three months ended in Mar. 2024 was $ -3.0 Mil. Tactile Systems Technology's Interest Expense for the three months ended in Mar. 2024 was $ 0.0 Mil. GuruFocus does not calculate Tactile Systems Technology's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tactile Systems Technology Interest Expense Historical Data

The historical data trend for Tactile Systems Technology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Interest Expense Chart

Tactile Systems Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

Tactile Systems Technology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Tactile Systems Technology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Tactile Systems Technology (NAS:TCMD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tactile Systems Technology's Interest Expense for the three months ended in Mar. 2024 was $0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-3.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $43.3 Mil.

Tactile Systems Technology's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Tactile Systems Technology's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Tactile Systems Technology (Tactile Systems Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

3L3:Germany

Address

3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416

Website

https://www.tactilemedical.com

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Executives

Boyd Vindell Washington	director	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers	director, officer: President and CEO	INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler	officer: Senior VP, Sales	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke	director	3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns	officer: Sr. VP Mktg & Clinical Affairs	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls	officer: Senior VP, Sales	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer	officer: Chief Financial Officer	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen	officer: Chief Financial Officer	3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer	director	2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe	officer: Vice President, Sales	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys	director, officer: Chief Executive Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413